表紙:糖尿病治療機器の世界市場:現状分析と予測(2021年~2027年)
市場調査レポート
商品コード
1069405

糖尿病治療機器の世界市場:現状分析と予測(2021年~2027年)

Diabetes Care Devices Market: Current Analysis and Forecast (2021-2027)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 248 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
糖尿病治療機器の世界市場:現状分析と予測(2021年~2027年)
出版日: 2022年02月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の糖尿病治療機器の市場規模は、予測期間(2021年~2027年)に約6%のCAGRが見込まれています。

ヒト用インスリン送達システムの進歩、インスリン送達システム技術の革新、償還政策、糖尿病管理に関する国民の意識の高まりなどが、市場の成長を促進する要因となっています。

当レポートでは、世界の糖尿病治療機器市場について調査しており、市場要約、市場の洞察、市場機会、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場のイントロダクション

  • 市場の定義
  • 制限
  • ステークホルダー
  • レポートで使用される通貨

第2章 調査手法または仮定

  • 糖尿病治療機器市場の調査プロセス
  • 糖尿病治療機器市場の調査手法
  • 予測方法
  • 回答者のプロファイル
  • 糖尿病治療機器市場調査の主な目的

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 糖尿病治療機器市場のCOVID-19の影響

第6章 糖尿病治療機器市場の収益(2019年~2027年)

第7章 市場の洞察:タイプ別

  • モニタリング装置
    • 血糖の自己モニタリング
    • グルコースの継続モニタリング
  • 管理デバイス
    • インスリンポンプ
    • インスリン注射器
    • インスリンカートリッジ
    • 使い捨てペン
    • ジェットインジェクター

第8章 市場の洞察:エンドユーザー別

  • 患者/在宅医療
  • 病院とクリニック

第9章 市場の洞察:地域別

  • 北米の糖尿病治療機器市場
    • 米国
    • カナダ
    • その他の北米
  • 欧州の糖尿病治療機器市場
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋の糖尿病治療機器市場
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他のアジア太平洋
  • その他

第10章 糖尿病治療機器市場の市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第11章 糖尿病治療機器市場機会

第12章 糖尿病治療機器の市場動向

第13章 糖尿病治療装置と規制の枠組み

第14章 需要と供給側の分析

  • 需要側分析
  • 供給側分析

第15章 バリューチェーン分析

第16章 競合シナリオ

  • 競合情勢
    • 企業シェア:収益別

第17章 企業概要

  • Medtronic
  • DexCom, Inc.
  • F. Hoffmann-La Roche AG
  • Novo Nordisk A/S
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Tandem Diabetes are, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG

第18章 免責事項

目次
Product Code: UMHE21683

Diabetes Care Devices Market is expected to grow at a CAGR of around 6% over the forecast period (2021-2027). The rise of this market is fueled by a growing diabetic population, obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market's growth.

Several government organizations are focusing on boosting the existing infrastructure for overall healthcare system development. Among the countries worldwide, the United States had the highest percentage of gross domestic product spent on health care in 2019. The U.S. spent nearly 17% of its GDP on health care services. Germany, Switzerland, and France followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries.

The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.

Some of the major players operating in the market include: Medtronic, DexCom, Inc., F. Hoffmann-La Roche AG, Novo Nordisk A/S, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Tandem Diabetes are, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

"Amongst Type, Insulin Pens segment dominated the market in 2020"

Based on Type, the market is segmented into Devices (Self-monitoring Blood Glucose (Glucometer Devices, Test Strips, Lancets), Continuous Glucose Monitoring (Sensors, Durables), Management Devices [Insulin Pumps (Insulin Pump Device, Insulin Pump Reservoir), Infusion Set, Insulin Syringes, Insulin Cartridges, Disposable Pens, Jet Injectors. The Monitoring Devices segment leads the Diabetes Care Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use home-based glucose monitoring devices to keep check on their diabetes readings.

"Amongst End-User, Patients/Homecare segment dominated the market in 2020."

Based on End-User, the Diabetes Care Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the diabetes care devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

"North America represents as the largest market."

For a better understanding of the market adoption of Diabetes Care Devices, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. Asia-Pacific dominated the market in 2020. North America dominated the market. The rising prevalence of diabetes and favorable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region's large share.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional & country-level analysis of the industry

Customization Options:

Diabetes Care Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Diabetes Care Devices Market
  • 2.2. Research Methodology of the Diabetes Care Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Diabetes Care Devices Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 DIABETES CARE DEVICES MARKET COVID-19 IMPACT

6 DIABETES CARE DEVICES MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Monitoring Devices
    • 7.1.1. Self-monitoring Blood Glucose
      • 7.1.1.1. Glucometer Devices
      • 7.1.1.2. Test Strips
      • 7.1.1.3. Lancets
    • 7.1.2. Continuous Glucose Monitoring
      • 7.1.2.1. Sensors
      • 7.1.2.2. Durables
  • 7.2. Management Devices
    • 7.2.1. Insulin Pumps
      • 7.2.1.1. Insulin Pump Device
      • 7.2.1.2. Insulin Pump Reservoir
      • 7.2.1.3. Infusion Set
    • 7.2.2. Insulin Syringes
    • 7.2.3. Insulin Cartridges
    • 7.2.4. Disposable Pens
    • 7.2.5. Jet Injectors

8 MARKET INSIGHTS BY END-USER

  • 8.1. Patients/Homecare
  • 8.2. Hospitals & Clinics

9 MARKET INSIGHTS BY REGION

  • 9.1. NORTH AMERICA DIABETES CARE DEVICES MARKET
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. EUROPE DIABETES CARE DEVICES MARKET
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. United Kingdom
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. ASIA-PACIFIC DIABETES CARE DEVICES MARKET
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. Rest of Asia Pacific
  • 9.4. REST OF WORLD DIABETES CARE DEVICES MARKET

10 DIABETES CARE DEVICES MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 DIABETES CARE DEVICES MARKET OPPORTUNITIES

12 DIABETES CARE DEVICES MARKET TRENDS

13 DIABETES CARE DEVICES & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. COMPETITIVE LANDSCAPE
    • 16.1.1. Company Shares, By Revenue

17 COMPANY PROFILED

  • 17.1. Medtronic
  • 17.2. DexCom, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Novo Nordisk A/S
  • 17.5. Johnson & Johnson
  • 17.6. Abbott Laboratories
  • 17.7. Becton, Dickinson and Company
  • 17.8. Tandem Diabetes are, Inc.
  • 17.9. Ascensia Diabetes Care Holdings AG
  • 17.10. B. Braun Melsungen AG

18 DISCLAIMER